While the manufacturer'sliability for a drug's warningdefect is a strict one, we shouldexplorewhether the drug manufacturer has exercised a dutyofcare that is adequate, continuous and immediate.
But the positive report, which matched Wall Street expectations, comes on the heels of a warning letter from the Food and Drug Administration that reprimands the company for failing to correct a longstanding defect in one of its drug infusion pumps.